{{Rsnum
|rsid=4073054
|Gene=NR1I3
|Chromosome=1
|position=161230697
|Orientation=minus
|GMAF=0.247
|Gene_s=NR1I3,TOMM40L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 18.6 | 40.7 | 40.7
| HCB | 1.5 | 18.7 | 79.9
| JPT | 0.0 | 8.2 | 91.8
| YRI | 4.8 | 41.8 | 53.4
| ASW | 1.8 | 42.9 | 55.4
| CHB | 1.5 | 18.7 | 79.9
| CHD | 0.0 | 13.9 | 86.1
| GIH | 4.0 | 33.7 | 62.4
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.8 | 49.1 | 49.1
| MKK | 0.0 | 13.6 | 86.4
| TSI | 15.7 | 47.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=20218903
|Title=Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers
}}

{{PMID Auto
|PMID=23462807
|Title=Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
|OA=1
}}

{{PMID Auto
|PMID=23492909
|Title=Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}